Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tal Freund

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Frontiers in Immunology|October 5, 2020
Monogenic Inflammatory Bowel Disease: It's Never Too Late to Make a DiagnosisIddo Vardi, Irit Chermesh, Lael Werner, et al.
Journal of Clinical Immunology|September 5, 2022
Clinically Complex LRBA Deficiency Due to a Founder Allele in the Georgian Jewish PopulationTal Freund, Sarah K Baxter, Tom Walsh, et al.
Transplantation Proceedings|March 29, 2022
Humoral Response to the Third Dose of Sars-Cov-2 Vaccine in Kidney Transplant RecipientsAyelet Grupper, Liane Rabinowich, Merav Ben-Yehoyada, et al.
Annals of the Rheumatic Diseases|July 22, 2022
Immunogenicity induced by two and three doses of the BNT162b2 mRNA vaccine in patients with autoimmune inflammatory rheumatic diseases and immunocompetent controls: a longitudinal multicentre studyVictoria Furer, Tali Eviatar, Tal Freund, et al.
Transplantation and Cellular Therapy|July 2, 2021
Safety and Immunogenicity of the BNT162b2 mRNA COVID-19 Vaccine in Patients after Allogeneic HCT or CD19-based CART therapy-A Single-Center Prospective Cohort StudyRon Ram, David Hagin, Nino Kikozashvilli, et al.
Medrxiv : the Preprint Server for Health Sciences|September 15, 2025
Autoantibodies neutralizing type I IFNs in 40% of patients with WNV encephalitis in seven new cohortsAdrian Gervais, Francesca Trespidi, Alessandro Ferrari, et al.
Journal of Human Immunity|March 16, 2026
Autoantibodies neutralizing type I IFNs in 40% of patients with WNV encephalitis in seven new cohortsAdrian Gervais, Francesca Trespidi, Alessandro Ferrari, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Frontiers in Immunology|October 5, 2020
Monogenic Inflammatory Bowel Disease: It's Never Too Late to Make a DiagnosisIddo Vardi, Irit Chermesh, Lael Werner, et al.
Journal of Clinical Immunology|September 5, 2022
Clinically Complex LRBA Deficiency Due to a Founder Allele in the Georgian Jewish PopulationTal Freund, Sarah K Baxter, Tom Walsh, et al.
Transplantation Proceedings|March 29, 2022
Humoral Response to the Third Dose of Sars-Cov-2 Vaccine in Kidney Transplant RecipientsAyelet Grupper, Liane Rabinowich, Merav Ben-Yehoyada, et al.
Annals of the Rheumatic Diseases|July 22, 2022
Immunogenicity induced by two and three doses of the BNT162b2 mRNA vaccine in patients with autoimmune inflammatory rheumatic diseases and immunocompetent controls: a longitudinal multicentre studyVictoria Furer, Tali Eviatar, Tal Freund, et al.
Transplantation and Cellular Therapy|July 2, 2021
Safety and Immunogenicity of the BNT162b2 mRNA COVID-19 Vaccine in Patients after Allogeneic HCT or CD19-based CART therapy-A Single-Center Prospective Cohort StudyRon Ram, David Hagin, Nino Kikozashvilli, et al.
Medrxiv : the Preprint Server for Health Sciences|September 15, 2025
Autoantibodies neutralizing type I IFNs in 40% of patients with WNV encephalitis in seven new cohortsAdrian Gervais, Francesca Trespidi, Alessandro Ferrari, et al.
Journal of Human Immunity|March 16, 2026
Autoantibodies neutralizing type I IFNs in 40% of patients with WNV encephalitis in seven new cohortsAdrian Gervais, Francesca Trespidi, Alessandro Ferrari, et al.
Pageof 2